Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation

Journal of Pharmacology and Experimental Therapeutics

Volumn 332, Issue 1, 2010, Pages 116-124

  Mugabe, Benon E ^a   Yaghini, Fariborz A ^a   Song, Chi Young ^a   Buharalioglu, Cuneyt K ^a   Waters, Christopher M ^a   Malik, Kafait U ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANGIOTENSIN II; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PICEATANNOL; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; BUTADIENES; CELL CULTURE TECHNIQUES; CELL MIGRATION ASSAYS; CELL MOVEMENT; CELLS, CULTURED; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUSCLE, SMOOTH, VASCULAR; NITRILES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTIONAL ACTIVATION; TYRPHOSTINS;

EID: 73949132149     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.157552     Document Type: Article

References (37)

1. Alonso G, Ambrosino C, Jones M, and Nebreda AR (2000) Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength. J Biol Chem 275:40641-40648.
2. Brilla CG, Maisch B, Rupp H, Funck R, Zhou G, and Weber KT (1995) Pharmacological modulation of cardiac fibroblast function. Herz 20:127-134.
3. Clempus RE and Griendling KK (2006) Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res 71:216-225.
4. Conrad PW, Rust RT, Han J, Millhorn DE, and Beitner-Johnson D (1999) Selective activation of p38α and p38γ by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J Biol Chem 274:23570- 23576.
5. de Cavanagh EM, Ferder M, Inserra F, and Ferder L (2009) Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint. Am J Physiol Heart Circ Physiol 296:H550-H558.
6. Eguchi S, Dempsey PJ, Frank GD, Motley ED, and Inagami T (2001) Activation of MAP kinases by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAP kinase but not JNK. J Biol Chem 276:7957-7962.
7. Eguchi S, Iwasaki H, Inagami T, Numaguchi K, Yamakawa T, Motley ED, Owada KM, Marumo F, and Hirata Y (1999) Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension 33:201-206.
8. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, et al. (1998) Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin IIinduced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273:8890-8896.
9. Feng TC, Ying WY, Hua RJ, Ji YY, and de Gasparo M (2001) Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade. J Renin Angiotensin Aldosterone Syst 2:19-24.
10. Gibbons GH, Pratt RE, and Dzau VJ (1992) Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J Clin Invest 90:456-461.
11. Hale KK, Trollinger D, Rihanek M, and Manthey CL (1999) Differential expression and activation of p38 mitogen-activated protein kinase α,β, γ, and in inflammatory cell lineages. J Immunol 162:4246-4252.
12. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
13. Kobori H, Nangaku M, Navar LG, and Nishiyama A (2007) The intrarenal reninangiotensin system: from physiology to the pathophysiology of hypertension and kidney disease. Pharmacol Rev 59:251-287.
14. Kurosaki T, Takata M, Yamanashi Y, Inazu T, Taniguchi T, Yamamoto T, and Yamamura H (1994) Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. J Exp Med 179:1725-1729.
15. Kyaw M, Yoshizumi M, Tsuchiya K, Kagami S, Izawa Y, Fujita Y, Ali N, Kanematsu Y, Toida K, Ishimura K, et al. (2004) Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation. Mol Pharmacol 65:832-841.
16. Lee HM, Lee CK, Lee SH, Roh HY, Bae YM, Lee KY, Lim J, Park PJ, Park TK, Lee YL, et al. (2007) p38 mitogen-activated protein kinase contributes to angiotensin II-stimulated migration of rat aortic smooth muscle cells. J Pharmacol Sci 105: 74-81.
17. Natarajan R, Scott S, Bai W, Yerneni KK, and Nadler J (1999) Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions. Hypertension 33:378-884.
18. Navar LG (1997) The kidney in blood pressure regulation and development of hypertension. Med Clin North Am 81:1165-1198.
19. Ohtsu H, Mifune M, Frank GD, Saito S, Inagami T, Kim-Mitsuyama S, Takuwa Y, Sasaki T, Rothstein JD, Suzuki H, et al. (2005) Signal-crosstalk between Rho/ ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II. Arterioscler Thromb Vasc Biol 25:1831-1836.
20. Rakugi H, Wang DS, Dzau VJ, and Pratt RE (1994) Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation 90:449-455.
21. Rocic P and Lucchesi PA (2001) Down-regulation by antisense oligonucleotides establishes a role for the proline-rich tyrosine kinase PYK2 in angiotensin II-induced signaling in vascular smooth muscle. J Biol Chem 276:21902-21906.
22. Sadoshima J and Izumo S (1993) Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73:413-423.
23. Saito S, Frank GD, Motley ED, Dempsey PJ, Utsunomiya H, Inagami T, and Eguchi S (2002) Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation. Biochem Biophys Res Commun 294:1023-1029.
24. Servant MJ, Giasson E, and Meloche S (1996) Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J Biol Chem 271:16047-16052.
25. Stover DR, Becker M, Liebetanz J, and Lydon NB (1995) Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85α. J Biol Chem 270:15591-15597.
26. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, and Egido J (2003) Inflammation and angiotensin II. Int J Biochem Cell Biol 35:881-900.
27. Touyz RM (2003) The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 5:155-164.
28. Touyz RM (2004) Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease. Braz J Med Biol Res 37:1263-1273.
29. Touyz RM, He G, Wu XH, Park JB, Mabrouk ME, and Schiffrin EL (2001) Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension 38:56-64.
30. Touyz RM and Schiffrin EL (2000) Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52:639-672.
31. Touyz RM, Wu XH, He G, Salomon S, and Schiffrin EL (2002) Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 39:479-485.
32. Uddin MR, Muthalif MM, Karzoun NA, Benter IF, and Malik KU (1998) Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. Hypertension 31:242-247.
33. Waters CM and Savla U (1999) Keratinocyte growth factor accelerates wound closure in airway epithelium during cyclic mechanical strain. J Cell Physiol 181:424-432.
34. Weber H, Taylor DS, and Molloy CJ (1994) Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin. J Clin Invest 93:788-798.
35. Weiss D, Sorescu D, and Taylor WR (2001) Angiotensin II and atherosclerosis. Am J Cardiol 87:25C-32C.
36. Xi XP, Graf K, Goetze S, Fleck E, Hsueh WA, and Law RE (1999) Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19:73-82.
37. Yaghini FA, Li F, and Malik KU (2007) Expression and mechanism of spleen tyrosine kinase activation by angiotensin II and its implication in protein synthesis in rat vascular smooth muscle cells. J Biol Chem 282:16878-16890.